Skip to main content
Home

Main navigation

  • About Ipnet
    • What is Ipnet ?
    • Statutes & bylaws
    • Membership application
    • Expert Clinical Center application
    • Ipnet Executive Board
    • General Assemblies
    • Ipnet Working Groups
    • Porphyria centres
    • Patient organizations
    • Corporate members
    • Honorary members
  • Patients
    • Introduction to porphyria
    • GPAC information statement
    • Acute porphyria
    • Drugs and acute hepatic porphyrias
    • Acute porphyria - diagnosis - FAQ
    • Porphyria Cutanea Tarda (PCT)
    • Erythropoietic Protoporphyrias (EPP & XLP)
    • Congenital erythropoietic porphyria (CEP)
    • Skin Protection in Cutaneous Porphyria
    • Patient organizations
    • Porphyria centres
  • Professionals
    • The porphyrias
    • Laboratory diagnosis
    • Investigating the family
    • Treatment of the acute attack
    • Drugs and acute hepatic porphyrias
    • Acute porphyria: how to refer a patient
    • Porphyria Cutanea Tarda (PCT)
    • Erythropoietic protoporphyria (EPP & XLEPP)
    • Webinars
    • Porphyria centres
  • News
  • Research
  • Contact

Corporate members

Agios Pharmaceuticals
Alnylam Switzerland GmbH
Clinuvel Pharmaceuticals LTD
Disc Medicine
Mitsubishi Tanabe Pharma Development America
Moderna Inc
Recordati Rare Diseases SARL

Home | Disclaimer | GDPR